Hiv

As it does every year, the Conference on Retroviruses and Opportunistic Infections is shining a spotlight on emerging research in HIV over the course of 4 days, this year at the Colorado Convention Center in Denver.

An HHS panel recommended this week that people with HIV begin taking a statin as young as age 40 years to lower their risk for a serious cardiac event, even if their risk for heart disease is in the low-to-moderate range.

Results from an ongoing trial showed that long-acting injectable ART for HIV is effective for people who struggle to consistently take a daily course of medication, the NIH and ViiV Healthcare announced.

The Coalition for Epidemic Preparedness Innovation, or CEPI, is spending $14.9 million to develop rapid tests for Nipah virus and Lassa fever.

Ritonavir crystals grown in low Earth orbit landed in a spacecraft in the Utah desert Wednesday, completing the manufacturing portion of a proof-of-concept manufacturing effort.

Many women with HIV reported using contraceptives in a survey, but just over half remembered having a conversation with a provider about them, results showed.

Researchers developed an artificial intelligence tool that can accurately determine whether a person is at average or high risk for contracting HIV, syphilis, gonorrhea and chlamydia.

People with HIV continue to have a higher risk of invasive meningococcal disease compared with people without HIV regardless of the 2016 recommendation that people with HIV receive routine vaccination for invasive meningococcal disease.